Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Study for Evaluation of Safety and Effectiveness of Rinvoq in Moderately to Severely Active Ulcerative Colitis; a Japanese Post-Marketing Study

NCT05791526 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT05791526
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05791526 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Study for Evaluation of Safety and Effectiveness of Rinvoq in Moderately to Severely Active Ulcerative Colitis; a Japanese Post-Marketing Study
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
December 19, 2022
Completion date
December 9, 2025
Enrollment
308 (actual)
Sites
114

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis